DENISE GEISLER: Open Payments
NPI 1497814289 · BOWLING GREEN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 17 payments from 9 companies in 2025. Trend: 2023 $131 · 2024 $176 · 2025 $440
Food & beverage: $329Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $155 |
| ABBVIE INC. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| PFIZER INC. | 3 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: REXULTI, NURTEC ODT, AUSTEDO XR, VRAYLAR, INGREZZA, FANAPT, CAPLYTA, UBRELVY.
Industry payments across MO — which companies pay providers there.
